September 14 -- The China Securities Regulatory Commission approved the initial public offering (IPO) applications of one company to list on the ChiNext Board and two companies to list on the Main Board of the Shenzhen Stock Exchange, reports Shanghai Securities News.
Walvax Biotechnology, a Yunnan-based company engaged in the production and sale of vaccine products for human use, plans to list on the ChiNext Board and issue 25 million shares in its IPO.
Following the completion of its IPO, its total share capital will reach 100 million shares.
Proceeds from the IPO will be used to invest in five projects related to the expansion of vaccine production. Total investment required is 415 million yuan.
Jilin Liyuan Aluminum, a company engaged in the deep processing of aluminum products, plans to list on the Shenzhen Stock Exchange.
It will issue 23.6 million shares in its IPO, following which its total share capital will reach 93.6 million shares.
Part of the proceeds from its IPO, totaling 436 million yuan, will be used in projects related to aluminum deep processing projects.
Kelin Environmental Protection Equipment, a company engaged in the production and sale of bag type dust filters as well as the development of bag dust filter systems, will list on the Shenzhen Stock Exchange. It plans to issue 19 million shares in its IPO.
Proceeds from its IPO will be used in an expansion project for its bag type dust filter equipment which requires a total investment of 199 million yuan.